Patent details

Basic Information

Publication number:

EP2540704

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP121813919

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Benethamine salt forms of atorvastatin

French Title of Invention:

Formes de sel de bénéthamine avec l'atorvastatine

German Title of Invention:

Formen von Atorvastatinsalzen mit Benethamin

SPC Number:

Dates

Filing date:

25/04/2005

Grant date:

03/07/2019

EP Publication Date:

02/01/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/07/2019

EP B1 Publication Date:

03/07/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/04/2020

Expiration date:

25/04/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/06/2019

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, CT 06340, United States (US)

Inventor

1

Name:

Campeta, Anthony, Michael

Address:

United States (US)

2

Name:

Krzyzaniak, Joseph, F.

Address:

United States (US)

3

Name:

Leonard, Jason, A.

Address:

United States (US)

Priority

Priority Number:

568379 P

Priority Date:

05/05/2004

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/40; C07D 207/34;

Publication

European Patent Bulletin

1

Issue number:

201927

Publication date:

03/07/2019

Description:

Grant (B1)

2

Issue number:

201931

Publication date:

31/07/2019

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages